RANDOMIZED PHASE II TRIAL OF CONCURRENT CHEMORADIOTHERAPY +/- METFORMIN HCL IN LOCALLY ADVANCED NSCLC (NRG-LU001)
Sponsor: NRG Oncology
Protocol number: NRG-LU001
Projected enrollment dates: December 2014 to December 2017
Official study title: RANDOMIZED PHASE II TRIAL OF CONCURRENT CHEMORADIOTHERAPY +/- METFORMIN HCL IN LOCALLY ADVANCED NSCLC (NRG-LU001)
ClinicalTrials.gov page:
http://www.clinicaltrials.gov/show/NCT02186847